Cila Therapeutics
Todd Astor is the Head of Clinical Development at Cila Therapeutics. Previously, Todd was a Medical Director, Lung and Heart-Lung Transplant Program at Nationwide Children's Hospital.
Todd holds an MBA from MIT Sloan School of Management.
Cila Therapeutics
Cila Therapeutics is a clinic-ready stage, a biotechnology company developing new inhaled therapies for respiratory diseases, leading with an inhaled treatment of a rare genetic disorder, Primary Ciliary Dyskinesia, or PCD.